Douglas Wisniewski

Statistics

Publications

Citations

1.7K

H-Index

Active since

1996

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Target (United States)

Massachusetts General Hospital

Douglas Wisniewski is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, molecular biology, and biochemistry.

ORCID

Publications per year

1996–2019

Publications

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart et al. · Science · 2017 · 344 citations

Life Sciences, Biochemistry, Pharmacology +17

Crystal Structure of Inhibitor-Bound Human 5-Lipoxygenase-Activating Protein

Andrew D. Ferguson, Brian M. McKeever, Shihua Xu et al. · Science · 2007 · 225 citations

Life Sciences, Medicinal Chemistry, Pharmacology +15

Anthrax lethal factor inhibition

Wesley L. Shoop, Y. XIONG, Judyann Wiltsie et al. · Proceedings of the National Academy of Sciences · 2005 · 176 citations

Life Sciences, Biochemistry, Pharmacology +17

A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo1[S]

Ni Yan, Stefania Di Marco, Jon H. Condra et al. · Journal of Lipid Research · 2010 · 133 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

Katherine Young, Ronald E. Painter, Susan L. Raghoobar et al. · BMC Microbiology · 2019 · 125 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

1–5 of 17